NBY: NovaBay Net earnings per share growth forecast for next year

NBY (NovaBay Pharmaceuticals, Inc.) - company brandmark

NovaBay Pharmaceuticals (NBY) ensures production sterility through robotic filling systems. The company's forward EPS dynamics model confirms analysts' confidence in this approach, and 0.00 becomes the new value for this metric. The issuer is implementing eco-friendly packaging standards and energy efficiency. Revenue stability is supported by Avenova eyelid hygiene patents and developed online sales.

NBY - NovaBay Pharmaceuticals Inc. Net earnings per share growth forecast for next year over the range 07/04/2022 - 04/18/2026

Comprehensive metric breakdowns and analytics for NovaBay Pharmaceuticals Inc. (NBY)

Basic company analysis:NovaBay Pharmaceuticals
Finished products of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals (NBY) maintains strong niche positions through the development of unique antimicrobial formulations for ophthalmology. Analyzing the projected change in earnings per share for the coming year, the investor assesses the expected EPS dynamics, which reflect the analysts' consensus forecast for future profitability. The stability of this indicator confirms the effectiveness of R&D investments in the Avenova product, whereas sharp fluctuations signal uncertainty regarding the asset's fundamental value.

Competitors of NovaBay Pharmaceuticals

ALC (Alcon Corp) - Earnings growth forecast for next year|Bausch + Lomb Corporation (BLCO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GKOS|Earnings growth forecast for next year Apellis Pharmaceuticals, Inc. (APLS)|Earnings growth forecast for next year BLTE (Belite Bio)|OCUL - Expected earnings per share growth for next year|HROW - Net earnings per share growth forecast for next year|Expected earnings per share trend next year VRDN (Viridian Therapeutics)|LENZ (LENZ Therapeutics, Inc.) - Expected earnings per share growth for next year|Oculis Holding AG - Expected earnings per share trend next year|Net earnings per share growth forecast for next year eyepointpharma.com|Earnings growth forecast for next year Kodiak Sciences Inc.|Net earnings per share growth forecast for next year Aldeyra Therapeutics Inc. (ALDX)|Net earnings per share growth forecast for next year KALA (KALA BIO)|Net earnings per share growth forecast for next year opusgtx.com IRD|Expected earnings per share trend next year OKYO|ADVM: Expected earnings per share growth for next year|Expected earnings per share trend next year OTLK (Outlook Therapeutics)|CLSD: Earnings growth forecast for next year|Kiora Pharma (KPRX) - Earnings growth forecast for next year|ALIM (alimerasciences.com) - Earnings growth forecast for next year|eyenovia.com (EYEN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GHSI|OCUP (Ocuphire) - Expected earnings per share trend next year|Earnings growth forecast for next year OPT (Opthea Ltd)